<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T12:17:04Z</responseDate>
  <request identifier="oai:figshare.com:article/33813365" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33813365</identifier>
        <datestamp>2026-09-15T17:50:28Z</datestamp>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Microperimetry characteristics of patients referred to vision rehabilitation with myopic maculopathy (MM, n = 31 eyes) and age-related macular degeneration (AMD, n = 32 eyes) by presenting acuity [1].&lt;/p&gt;</dc:title>
          <dc:creator>Cody Lo (24579977)</dc:creator>
          <dc:creator>Mary Lou Jackson (5204459)</dc:creator>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>two independent reviewers</dc:subject>
          <dc:subject>reported priority goals</dc:subject>
          <dc:subject>related macular degeneration</dc:subject>
          <dc:subject>progressive degenerative change</dc:subject>
          <dc:subject>either eye better</dc:subject>
          <dc:subject>continue performing tasks</dc:subject>
          <dc:subject>high myopia leading</dc:subject>
          <dc:subject>vision rehabilitation showed</dc:subject>
          <dc:subject>visual challenges faced</dc:subject>
          <dc:subject>myopic maculopathy referred</dc:subject>
          <dc:subject>central vision loss</dc:subject>
          <dc:subject>mean age 68</dc:subject>
          <dc:subject>available microperimetry data</dc:subject>
          <dc:subject>presenting clinical characteristics</dc:subject>
          <dc:subject>vision rehabilitation compared</dc:subject>
          <dc:subject>0 vs 81</dc:subject>
          <dc:subject>visual acuity better</dc:subject>
          <dc:subject>prevalent amongst patients</dc:subject>
          <dc:subject>vision rehabilitation</dc:subject>
          <dc:subject>clinical characteristics</dc:subject>
          <dc:subject>visual acuity</dc:subject>
          <dc:subject>myopia globally</dc:subject>
          <dc:subject>visual impairment</dc:subject>
          <dc:subject>unique characteristics</dc:subject>
          <dc:subject>often referred</dc:subject>
          <dc:subject>moderate acuity</dc:subject>
          <dc:subject>central scotomas</dc:subject>
          <dc:subject>study compares</dc:subject>
          <dc:subject>significantly younger</dc:subject>
          <dc:subject>significant trend</dc:subject>
          <dc:subject>rising prevalence</dc:subject>
          <dc:subject>optical devices</dc:subject>
          <dc:subject>new strategies</dc:subject>
          <dc:subject>increase due</dc:subject>
          <dc:subject>help adapt</dc:subject>
          <dc:subject>early stage</dc:subject>
          <dc:subject>disease processes</dc:subject>
          <dc:subject>common diagnosis</dc:subject>
          <dc:subject>choroid associated</dc:subject>
          <dc:subject>assistive technology</dc:subject>
          <dc:description>&lt;p&gt;Microperimetry characteristics of patients referred to vision rehabilitation with myopic maculopathy (MM, n = 31 eyes) and age-related macular degeneration (AMD, n = 32 eyes) by presenting acuity [&lt;a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0356824#pone.0356824.ref001" target="_blank"&gt;1&lt;/a&gt;].&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T17:50:22Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0356824.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Microperimetry_characteristics_of_patients_referred_to_vision_rehabilitation_with_myopic_maculopathy_MM_n_31_eyes_and_age-related_macular_degeneration_AMD_n_32_eyes_by_presenting_acuity_1_p_/33813365</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
